Figure 8.

A Western blots of connexin 43 (Cx43) using monoclonal antibody for Cx43 (Zymed Laboratories Inc, USA) in the ventricles of the phorbol 12-myristate 13-acetate (PMA)-treated (0.1 μmol/L, 60 min), the streptozotocin (STZ)-induced diabetic and the Otsuka Long-Evans Tokushima Fatty (OLETF) rat hearts. Control, normal and Long-Evans Tokushima Otsuka (LETO) hearts were the control hearts for the PMA-treated, the STZ-induced diabetic and the OLETF hearts, respectively. B A statistical analysis of the Western blots – a comparison of the quantity of Cx43 among the PMA-treated, the STZ-induced diabetic and the OLETF rat hearts; the columns represent the relative value (1.0 is the value of the control, normal and LETO hearts), and the vertical bars represent the mean ± SEM. *P<0.001 versus the control, normal and LETO hearts